Inventor · disambiguated record
Ashok Katdare
Also filed as: KATDARE ASHOK · KATDARE ASHOK V
30 granted patents·30 pending applications·818 citations·filing 1985–2019
98Inventor score
Files withMERCK & CO INC28ADAMAS PHARMACEUTICALS INC14ADAMAS PHARMA LLC6KATDARE ASHOK V2ADARMAS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
60 records- 0196US9877933B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 30, 2018·15 cites·31 claims
- 0296US9867793B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 16, 2018·15 cites·43 claims
- 0396US9867791B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 16, 2018·17 cites·56 claims
- 0496US9867792B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 16, 2018·15 cites·19 claims
- 0596US8741343B2Method of administering amantadine prior to a sleep periodWENT GREGORY T·Filed 2010·Granted Jun 3, 2014·29 cites·29 claims
- 0694US5358941ADry mix formulation for bisphosphonic acids with lactoseMERCK & CO INC·Filed 1992·Granted Oct 25, 1994·95 cites·8 claims
- 0791US6623755B2Pharmaceutical tabletsMERCK & CO INC·Filed 2002·Granted Sep 23, 2003·53 cites·18 claims
- 0891US5882656ADry mix formulation for bisphosphonic acidsMERCK & CO INC·Filed 1997·Granted Mar 16, 1999·69 cites·1 claims
- 0990US5462932AOral liquid alendronate formulationsMERCK & CO INC·Filed 1994·Granted Oct 31, 1995·102 cites·25 claims
- 1089US7060294B2Compressed tablet formulationMERCK & CO INC·Filed 2001·Granted Jun 13, 2006·37 cites·14 claims
- 1189US6692764B2Wet granulation formulation for bisphosphonic acidsMERCK & CO INC·Filed 2002·Granted Feb 17, 2004·21 cites·15 claims
- 1288US11197835B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2019·Granted Dec 14, 2021·2 cites·16 claims
- 1388US5681590ADry mix formulation for bisphosphonic acidsMERCK & CO INC·Filed 1993·Granted Oct 28, 1997·50 cites·17 claims
- 1486USD375157STabletMERCK & CO INC·Filed 1992·Granted Oct 29, 1996·27 cites·1 claims
- 1585US5853759AEffervescent alendronate formulationMERCK & CO INC·Filed 1997·Granted Dec 29, 1998·59 cites·5 claims
- 1684USD430285STabletMERCK & CO INC·Filed 1999·Granted Aug 29, 2000·30 cites·1 claims
- 1783USD379223SPharmaceutical tabletMERCK & CO INC·Filed 1995·Granted May 13, 1997·27 cites·1 claims
- 1880USD431076STabletMERCK & CO INC·Filed 1999·Granted Sep 19, 2000·25 cites·1 claims
- 1980USD400672SPharmaceutical tabletMERCK & CO INC·Filed 1996·Granted Nov 3, 1998·23 cites·1 claims
- 2076US6406714B1Dry mix formulation for bisphosphonic acidsMERCK & CO INC·Filed 2000·Granted Jun 18, 2002·5 cites·1 claims
- 2173US6090410ADry mix formulation for bisphosphonic acidsMERCK & CO INC·Filed 1998·Granted Jul 18, 2000·21 cites·13 claims
- 2272US6517867B2Dry mix formulation for bisphosphonic acidsMERCK & CO INC·Filed 2001·Granted Feb 11, 2003·2 cites·25 claims
- 2372US2018263928A1Amantadine compositions and methods of useADAMAS PHARMA LLC·Filed 2018·Application pending·0 cites
- 2470US2015045446A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2570US2015051292A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2670US2015045438A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2770US2015045439A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2870US2015045448A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2970US2015045447A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3070US2015057355A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3169US2014242163A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3264US7595063B2Compressed tablet formulationMERCK & CO INC·Filed 2006·Granted Sep 29, 2009·0 cites·9 claims
- 3364US6194004B1Dry mix formulation for bisphosphonic acidsMERCK & CO INC·Filed 1999·Granted Feb 27, 2001·13 cites·25 claims
- 3464US2016263053A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3564US2016256414A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3664US2016151307A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3764US2016263057A1Amantadine compositions and methods of useADARMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3864US2016263056A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3964US2016263054A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4064US2004137056A1Wet granulation formulation for bisphosphonic acidsFiled 2003·Application pending·0 cites
- 4164US2016263055A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4260US4639458ATablet and formulationMERCK & CO INC·Filed 1985·Granted Jan 27, 1987·22 cites·3 claims
- 4359US2002137727A1Wet granulation formulation for bisphosphonic acidsMERCK & CO INC·Filed 2002·Application pending·0 cites
- 4459US2003003147A1Effer-vescent bisphosphonate formulationMERCK & CO INC·Filed 2002·Application pending·0 cites
- 4557US2001007863A1Wet granulation formulation for bisphosphonic acidsMERCK & CO INC·Filed 2001·Application pending·0 cites
- 4656US4898736AMethod for tablet preparationMERCK & CO INC·Filed 1988·Granted Feb 6, 1990·19 cites·2 claims
- 4756US2001041165A1Effervescent bisphosphonate formulationMERCK & CO INC·Filed 2001·Application pending·0 cites
- 4854USD380825SPharmaceutical tabletMERCK & CO INC·Filed 1994·Granted Jul 8, 1997·7 cites·1 claims
- 4954US2004137058A1Effervescent bisphosphonate formulationFiled 2004·Application pending·0 cites
- 5054US2005084525A1Method for blinding a medicationFiled 2004·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →